The single nucleotide polymorphism (SNP) of the estrogen receptor-β gene, rs1256049, is associated with knee osteoarthritis in Korean population

被引:9
作者
Lee, Suk Woo [1 ]
Song, Joo Hyoun [2 ]
Choi, Won Suk [1 ]
Yoon, Jung Hwan [1 ]
Kim, Olga [1 ]
Park, Yong Gyu [3 ]
Nam, Suk Woo [1 ]
Lee, Jung Young [1 ]
Park, Won Sang [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul 137701, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Orthoped, Seoul 137701, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul 137701, South Korea
基金
新加坡国家研究基金会;
关键词
Single nucleotide polymorphism; Genetic susceptibility; Osteoarthritis; ER-beta; Rsa polymorphism; BONE-MINERAL DENSITY; MESSENGER-RIBONUCLEIC-ACID; REPEAT POLYMORPHISM; ALPHA; GENOTYPES; THERAPY; HAPLOTYPE; ARTHRITIS; DISEASE; WOMEN;
D O I
10.1016/j.knee.2012.12.011
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Estrogens affect articular cartilage metabolism via estrogen receptors (ER) in chondrocytes and are believed to play an important role in the pathophysiology of osteoarthritis (OA). The aim of this study is to determine whether the single nucleotide polymorphism (SNP) of the estrogen receptor-beta (ER-beta) is associated with an increased susceptibility to knee OA. Methods: The possible influence of the SNP of the ER-beta was investigated in 286 OA patients and 294 healthy subjects as controls. A polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) assay and a PCR-single strand conformation polymorphism (SSCP) assay were used to identify the Rsa polymorphism genotype among healthy controls and OA patients, respectively. Results: For rs1256049 (Rsa), frequencies of genotypes GG, GA, and AA were 49.0% (144/294), 43.5% (128/294), and 7.5% (22/294) in healthy controls, and 35.3% (101/286), 45.5% (130/286), and 192% (55/286) in OA patients. Frequencies of alleles G and A among healthy controls were 70.7% (416/588) and 29.3% (172/588); whereas those among OA patients were 58.0% (332/572) and 42.0% (240/572). Statistically significant differences in allele and genotype frequencies of rs1256049 were observed between OA patients and controls (P<0.0001). In particular, the risk of OA was significantly increased in carriers with the rs1256049A allele and rs1256049 AA homozygotes. Conclusions: These results suggest a close association of rs1256049 ER-beta polymorphisms with susceptibility to OA in the Korean population. Clinical relevance: The rs1256049 polymorphism of the estrogen receptor-p gene can potentially be used to identify genetically high-risk subgroup of osteoarthritis in advance and to understand pathogenesis of osteoarthritis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 36 条
[1]  
Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001
[2]   Estrogenic hormone action in the heart: regulatory network and function [J].
Babiker, FA ;
De Windt, LJ ;
van Eickels, M ;
Grohe, C ;
Meyer, R ;
Doevendans, PA .
CARDIOVASCULAR RESEARCH, 2002, 53 (03) :709-719
[3]   Estrogen receptor α gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women [J].
Bergink, AP ;
van Meurs, JB ;
Loughlin, J ;
Arp, PP ;
Fang, Y ;
Hofman, A ;
van Leeuwen, JPTM ;
van Duijn, CM ;
Uitterlinden, AG ;
Pols, HAP .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1913-1922
[4]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[5]   Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse [J].
Couse, JF ;
Lindzey, J ;
Grandien, K ;
Gustafsson, JA ;
Korach, KS .
ENDOCRINOLOGY, 1997, 138 (11) :4613-4621
[6]   Selective estrogen receptor-β agonists repress transcription of proinflammatory genes [J].
Cvoro, Aleksandra ;
Tatomer, Deirdre ;
Tee, Meng-Kian ;
Zogovic, Tatjana ;
Harris, Heather A. ;
Leitman, Dale C. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (01) :630-636
[7]   THE EFFECT OF POSTMENOPAUSAL ESTROGEN THERAPY ON BONE-DENSITY IN ELDERLY WOMEN [J].
FELSON, DT ;
ZHANG, YQ ;
HANNAN, MT ;
KIEL, DP ;
WILSON, PWF ;
ANDERSON, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (16) :1141-1146
[8]   Estrogen and osteoarthritis: How do we explain conflicting study results? [J].
Felson, DT ;
Nevitt, MC .
PREVENTIVE MEDICINE, 1999, 28 (05) :445-448
[9]   Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model:: Responses to disease induction and therapy with the estrogen receptor-β selective agonist ERB-041 [J].
Follettie, MT ;
Pinard, M ;
Keith, JC ;
Wang, LL ;
Chelsky, D ;
Hayward, C ;
Kearney, P ;
Thibault, P ;
Paramithiotis, E ;
Dorner, AJ ;
Harris, HA .
ENDOCRINOLOGY, 2006, 147 (02) :714-723
[10]   Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women [J].
Han, KO ;
Moon, IG ;
Kang, YS ;
Chung, HY ;
Min, HK ;
Han, IK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :991-995